Zentalis Pharmaceuticals Inc

NASDAQ:ZNTL   3:59:50 PM EDT
20.76
-0.66 (-3.08%)
Earnings Announcements

Zentalis Pharmaceuticals Reports First Quarter 2022 Financial Results And Operational Update

Published: 05/05/2022 11:31 GMT
Zentalis Pharmaceuticals Inc (ZNTL) - Zentalis Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Update.
Qtrly Net Loss per Common Share Outstanding, Basic and Diluted $1.31.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$1.24

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$1.28

More details on our Analysts Page.